(c) GRANT APPLICATION STANDARDIZATION.—The 
Director, in consultation with the head of each National 
Drug Control Program Agency, shall develop a plan for 
coordinating and standardizing drug control grant appli-
cation processes and develop a joint application to be used 
by all National Drug Control Program Agencies to reduce 
the administrative burden and improve oversight of Fed-
eral funds. 
(d) CENTRAL PORTAL.—The Director shall maintain 
on the public, electronic portal of the Office a list all drug 
control grant award opportunities available in a central 
location. The head of each National Drug Control Pro-
gram Agency shall provide a complete list of all drug con-
trol program grant award opportunities to the Director 
and annually update such list. 
(e) REPORT TO CONGRESS.—Not later than 180 days 
after the date of the enactment of this Act, the Director 
shall submit to Congress a report on progress under this 
section and the feasibility of block grants of Federal fund-
ing to States. 
(f) DEFINITIONS.—In this section: 
(1) AGENCY.—The term ‘‘agency’’ has the 
meaning given the term ‘‘executive agency’’ in sec-
tion 102 of title 31, United States Code. 
VerDate Sep 11 2014 
01:01 Jun 05, 2018
Jkt 079200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5980.IH
H5980
dlhill on DSK3GLQ082PROD with BILLS
(2) DEMAND REDUCTION.—The term ‘‘demand 
reduction’’ means any activity conducted by a Na-
tional Drug Control Program Agency, other than an 
enforcement activity, that is intended to reduce or 
prevent the use of drugs or support or provide treat-
ment and recovery efforts, including— 
(A) education about the dangers of illicit 
drug use; 
(B) services, programs, or strategies to 
prevent substance use disorder, including evi-
dence-based education campaigns, community- 
based prevention programs, opioid diversion, 
collection and disposal of unused prescription 
drugs, and services to at-risk populations to 
prevent or delay initial use of an illicit sub-
stance; 
(C) substance use disorder treatment; 
(D) illicit drug use research; 
(E) drug-free workplace programs; 
(F) drug testing, including the testing of 
employees; 
(G) interventions for illicit drug use and 
dependence; 
VerDate Sep 11 2014 
01:01 Jun 05, 2018
Jkt 079200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5980.IH
H5980
dlhill on DSK3GLQ082PROD with BILLS
(H) expanding availability of access to 
health care services for the treatment of sub-
stance use disorders; 
(I) international drug control coordination 
and cooperation with respect to activities de-
scribed in this paragraph; 
(J) pre- and post-arrest criminal justice 
interventions such as diversion programs, drug 
courts, and the provision of evidence-based 
treatment to individuals with substance use dis-
orders who are arrested or under some form of 
criminal justice supervision, including medica-
tion assisted treatment; 
(K) other coordinated and joint initiatives 
among Federal, State, local, and Tribal agen-
cies to promote comprehensive drug control 
strategies designed to reduce the demand for, 
and the availability of, illegal drugs; 
(L) international illicit drug use education, 
prevention, treatment, recovery, research, reha-
bilitation activities, and interventions for illicit 
drug use and dependence; and 
(M) research related to any of the activi-
ties described in this paragraph. 
VerDate Sep 11 2014 
01:01 Jun 05, 2018
Jkt 079200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H5980.IH
H5980
dlhill on DSK3GLQ082PROD with BILLS
(3) DIRECTOR.—The term ‘‘Director’’ means 
the Director of the Office of National Drug Control 
Policy. 
(4) DRUG CONTROL.—The term ‘‘drug control’’ 
means any activity conducted by a National Drug 
Control Program Agency involving supply reduction 
or demand reduction. 
(5) ILLICIT DRUG USE; ILLICIT DRUGS; ILLE-
GAL DRUGS.—The terms ‘‘illicit drug use’’, ‘‘illicit 
drugs’’, and ‘‘illegal drugs’’ include the illegal or il-
licit use of prescription drugs. 
(6) NATIONAL DRUG CONTROL PROGRAM AGEN-
CY.—The term ‘‘National Drug Control Program 
Agency’’ means any agency (or bureau, office, inde-
pendent agency, board, division, commission, sub-
division, unit, or other component thereof) that is 
responsible for implementing any aspect of the Na-
tional Drug Control Strategy, including any agency 
that receives Federal funds to implement any aspect 
of the National Drug Control Strategy, but does not 
include any agency that receives funds for drug con-
trol activity solely under the National Intelligence 
Program or the Military Intelligence Program. 
(7) OFFICE.—The term ‘‘Office’’ means the Of-
fice of National Drug Control Policy. 
VerDate Sep 11 2014 
01:01 Jun 05, 2018
Jkt 079200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H5980.IH
H5980
dlhill on DSK3GLQ082PROD with BILLS
(8) STRATEGY.—The term ‘‘Strategy’’ means 
the National Drug Control Program Strategy. 
(9) SUPPLY
REDUCTION.—The term ‘‘supply 
reduction’’ means any activity or program conducted 
by a National Drug Control Program Agency that is 
intended to reduce the availability or use of illegal 
drugs in the United States or abroad, including— 
(A) law enforcement outside the United 
States; 
(B) domestic law enforcement; 
(C) source country programs, including 
economic development programs primarily in-
tended to reduce the production or trafficking 
of illicit drugs; 
(D) activities to control international traf-
ficking in, and availability of, illegal drugs, in-
cluding— 
(i) accurate assessment and moni-
toring of international drug production and 
interdiction programs and policies; and 
(ii) coordination and promotion of 
compliance with international treaties re-
lating to the production, transportation, or 
interdiction of illegal drugs; 
VerDate Sep 11 2014 
01:01 Jun 05, 2018
Jkt 079200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H5980.IH
H5980
dlhill on DSK3GLQ082PROD with BILLS
(E) activities to conduct and promote 
international law enforcement programs and 
policies to reduce the supply of drugs; 
(F) activities to facilitate and enhance the 
sharing of domestic and foreign intelligence in-
formation among National Drug Control Pro-
gram Agencies, relating to the production and 
trafficking of drugs in the United States and in 
foreign countries; 
(G) activities to prevent the diversion of 
drugs for their illicit use; and 
(H) research related to any of the activi-
ties described in this paragraph. 
Æ 
VerDate Sep 11 2014 
01:01 Jun 05, 2018
Jkt 079200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6301
E:\BILLS\H5980.IH
H5980
dlhill on DSK3GLQ082PROD with BILLS